Moderna has received FDA approval for its mRNA-based flu vaccine, named mFLUSIVA. This vaccine is now authorized for use in all adults aged 50 and older. The approval followed a review process that was described as a "rollercoaster." AI
RANK_REASON Product launch of a new vaccine by a major pharmaceutical company. [lever_c_demoted from significant: ic=1 ai=0.0]
Read on Mastodon — mastodon.social →
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
